{
  "ticker": "REGN",
  "year": 2024,
  "quarter": 1,
  "last_updated": "2025-04-19T09:36:19.551340",
  "count": 339,
  "transactions": [
    {
      "id": 14702,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-03-13",
      "transaction_shares": "20000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "68306"
    },
    {
      "id": 27659,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-03-13",
      "transaction_shares": "20000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "68306"
    },
    {
      "id": 44637,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-03-13",
      "transaction_shares": "20000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "68306"
    },
    {
      "id": 64357,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-03-13",
      "transaction_shares": "20000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "68306"
    },
    {
      "id": 86316,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-03-13",
      "transaction_shares": "20000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "68306"
    },
    {
      "id": 110549,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-03-13",
      "transaction_shares": "20000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "68306"
    },
    {
      "id": 136703,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-03-13",
      "transaction_shares": "20000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "68306"
    },
    {
      "id": 164847,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-03-13",
      "transaction_shares": "20000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "68306"
    },
    {
      "id": 195451,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-03-13",
      "transaction_shares": "20000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "68306"
    },
    {
      "id": 228344,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-03-13",
      "transaction_shares": "20000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "68306"
    },
    {
      "id": 263964,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-03-13",
      "transaction_shares": "20000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "68306"
    },
    {
      "id": 305232,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-03-13",
      "transaction_shares": "20000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "68306"
    },
    {
      "id": 14691,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-03-01",
      "transaction_shares": "358",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "13431"
    },
    {
      "id": 14698,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-01",
      "transaction_shares": "1",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "18381"
    },
    {
      "id": 27647,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-03-01",
      "transaction_shares": "358",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "13431"
    },
    {
      "id": 27654,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-01",
      "transaction_shares": "1",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "18381"
    },
    {
      "id": 44619,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-03-01",
      "transaction_shares": "358",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "13431"
    },
    {
      "id": 44626,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-01",
      "transaction_shares": "1",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "18381"
    },
    {
      "id": 64333,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-03-01",
      "transaction_shares": "358",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "13431"
    },
    {
      "id": 64343,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-01",
      "transaction_shares": "1",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "18381"
    },
    {
      "id": 86290,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-03-01",
      "transaction_shares": "358",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "13431"
    },
    {
      "id": 86300,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-01",
      "transaction_shares": "1",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "18381"
    },
    {
      "id": 110518,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-03-01",
      "transaction_shares": "358",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "13431"
    },
    {
      "id": 110531,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-01",
      "transaction_shares": "1",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "18381"
    },
    {
      "id": 136670,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-03-01",
      "transaction_shares": "358",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "13431"
    },
    {
      "id": 136685,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-01",
      "transaction_shares": "1",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "18381"
    },
    {
      "id": 164814,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-03-01",
      "transaction_shares": "358",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "13431"
    },
    {
      "id": 164829,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-01",
      "transaction_shares": "1",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "18381"
    },
    {
      "id": 195418,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-03-01",
      "transaction_shares": "358",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "13431"
    },
    {
      "id": 195433,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-01",
      "transaction_shares": "1",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "18381"
    },
    {
      "id": 228307,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-03-01",
      "transaction_shares": "358",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "13431"
    },
    {
      "id": 228325,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-01",
      "transaction_shares": "1",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "18381"
    },
    {
      "id": 263921,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-03-01",
      "transaction_shares": "358",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "13431"
    },
    {
      "id": 263942,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-01",
      "transaction_shares": "1",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "18381"
    },
    {
      "id": 305189,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-03-01",
      "transaction_shares": "358",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "13431"
    },
    {
      "id": 305210,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-01",
      "transaction_shares": "1",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "18381"
    },
    {
      "id": 14681,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1020",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "50999"
    },
    {
      "id": 14682,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "854",
      "transaction_price": "391.92",
      "transaction_type": "M",
      "shares_after_transaction": "2236"
    },
    {
      "id": 14683,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1000",
      "transaction_price": "990.0",
      "transaction_type": "S",
      "shares_after_transaction": "36543"
    },
    {
      "id": 14688,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 27636,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1020",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "50999"
    },
    {
      "id": 27637,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "854",
      "transaction_price": "391.92",
      "transaction_type": "M",
      "shares_after_transaction": "2236"
    },
    {
      "id": 27638,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1000",
      "transaction_price": "990.0",
      "transaction_type": "S",
      "shares_after_transaction": "36543"
    },
    {
      "id": 27644,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 44604,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1020",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "50999"
    },
    {
      "id": 44605,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "854",
      "transaction_price": "391.92",
      "transaction_type": "M",
      "shares_after_transaction": "2236"
    },
    {
      "id": 44606,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1000",
      "transaction_price": "990.0",
      "transaction_type": "S",
      "shares_after_transaction": "36543"
    },
    {
      "id": 44616,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 64314,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1020",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "50999"
    },
    {
      "id": 64315,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "854",
      "transaction_price": "391.92",
      "transaction_type": "M",
      "shares_after_transaction": "2236"
    },
    {
      "id": 64316,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1000",
      "transaction_price": "990.0",
      "transaction_type": "S",
      "shares_after_transaction": "36543"
    },
    {
      "id": 64329,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 86270,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1020",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "50999"
    },
    {
      "id": 86271,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "854",
      "transaction_price": "391.92",
      "transaction_type": "M",
      "shares_after_transaction": "2236"
    },
    {
      "id": 86272,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1000",
      "transaction_price": "990.0",
      "transaction_type": "S",
      "shares_after_transaction": "36543"
    },
    {
      "id": 86286,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 110493,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1020",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "50999"
    },
    {
      "id": 110494,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "854",
      "transaction_price": "391.92",
      "transaction_type": "M",
      "shares_after_transaction": "2236"
    },
    {
      "id": 110496,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1000",
      "transaction_price": "990.0",
      "transaction_type": "S",
      "shares_after_transaction": "36543"
    },
    {
      "id": 110514,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 136643,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1020",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "50999"
    },
    {
      "id": 136644,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "854",
      "transaction_price": "391.92",
      "transaction_type": "M",
      "shares_after_transaction": "2236"
    },
    {
      "id": 136646,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1000",
      "transaction_price": "990.0",
      "transaction_type": "S",
      "shares_after_transaction": "36543"
    },
    {
      "id": 136666,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 164785,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1020",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "50999"
    },
    {
      "id": 164786,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "854",
      "transaction_price": "391.92",
      "transaction_type": "M",
      "shares_after_transaction": "2236"
    },
    {
      "id": 164788,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1000",
      "transaction_price": "990.0",
      "transaction_type": "S",
      "shares_after_transaction": "36543"
    },
    {
      "id": 164810,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 195388,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1020",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "50999"
    },
    {
      "id": 195389,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "854",
      "transaction_price": "391.92",
      "transaction_type": "M",
      "shares_after_transaction": "2236"
    },
    {
      "id": 195391,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1000",
      "transaction_price": "990.0",
      "transaction_type": "S",
      "shares_after_transaction": "36543"
    },
    {
      "id": 195414,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 228270,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1020",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "50999"
    },
    {
      "id": 228271,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "854",
      "transaction_price": "391.92",
      "transaction_type": "M",
      "shares_after_transaction": "2236"
    },
    {
      "id": 228273,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1000",
      "transaction_price": "990.0",
      "transaction_type": "S",
      "shares_after_transaction": "36543"
    },
    {
      "id": 228302,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 263882,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1020",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "50999"
    },
    {
      "id": 263883,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "854",
      "transaction_price": "391.92",
      "transaction_type": "M",
      "shares_after_transaction": "2236"
    },
    {
      "id": 263886,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1000",
      "transaction_price": "990.0",
      "transaction_type": "S",
      "shares_after_transaction": "36543"
    },
    {
      "id": 263916,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 305150,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1020",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "50999"
    },
    {
      "id": 305151,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "854",
      "transaction_price": "391.92",
      "transaction_type": "M",
      "shares_after_transaction": "2236"
    },
    {
      "id": 305154,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1000",
      "transaction_price": "990.0",
      "transaction_type": "S",
      "shares_after_transaction": "36543"
    },
    {
      "id": 305184,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 14686,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "27349"
    },
    {
      "id": 14690,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "967.65",
      "transaction_type": "S",
      "shares_after_transaction": "37543"
    },
    {
      "id": 27641,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "27349"
    },
    {
      "id": 27646,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "967.65",
      "transaction_type": "S",
      "shares_after_transaction": "37543"
    },
    {
      "id": 44612,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "27349"
    },
    {
      "id": 44618,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "967.65",
      "transaction_type": "S",
      "shares_after_transaction": "37543"
    },
    {
      "id": 64325,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "27349"
    },
    {
      "id": 64332,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "967.65",
      "transaction_type": "S",
      "shares_after_transaction": "37543"
    },
    {
      "id": 86282,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "27349"
    },
    {
      "id": 86289,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "967.65",
      "transaction_type": "S",
      "shares_after_transaction": "37543"
    },
    {
      "id": 110510,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "27349"
    },
    {
      "id": 110517,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "967.65",
      "transaction_type": "S",
      "shares_after_transaction": "37543"
    },
    {
      "id": 136660,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "27349"
    },
    {
      "id": 136669,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "967.65",
      "transaction_type": "S",
      "shares_after_transaction": "37543"
    },
    {
      "id": 164804,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "27349"
    },
    {
      "id": 164813,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "967.65",
      "transaction_type": "S",
      "shares_after_transaction": "37543"
    },
    {
      "id": 195408,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "27349"
    },
    {
      "id": 195417,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "967.65",
      "transaction_type": "S",
      "shares_after_transaction": "37543"
    },
    {
      "id": 228295,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "27349"
    },
    {
      "id": 228305,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "967.65",
      "transaction_type": "S",
      "shares_after_transaction": "37543"
    },
    {
      "id": 263909,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "27349"
    },
    {
      "id": 263919,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "967.65",
      "transaction_type": "S",
      "shares_after_transaction": "37543"
    },
    {
      "id": 305177,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "27349"
    },
    {
      "id": 305187,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "967.65",
      "transaction_type": "S",
      "shares_after_transaction": "37543"
    },
    {
      "id": 4668,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "172723",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "925209"
    },
    {
      "id": 14693,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "172723",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "925209"
    },
    {
      "id": 27649,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "172723",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "925209"
    },
    {
      "id": 44621,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "172723",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "925209"
    },
    {
      "id": 64336,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "172723",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "925209"
    },
    {
      "id": 86293,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "172723",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "925209"
    },
    {
      "id": 110521,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "172723",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "925209"
    },
    {
      "id": 136674,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "172723",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "925209"
    },
    {
      "id": 164818,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "172723",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "925209"
    },
    {
      "id": 195422,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "172723",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "925209"
    },
    {
      "id": 228311,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "172723",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "925209"
    },
    {
      "id": 263926,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "172723",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "925209"
    },
    {
      "id": 305194,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "172723",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "925209"
    },
    {
      "id": 4666,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-14",
      "transaction_shares": "439",
      "transaction_price": "937.94",
      "transaction_type": "S",
      "shares_after_transaction": "30373"
    },
    {
      "id": 14689,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-14",
      "transaction_shares": "439",
      "transaction_price": "937.94",
      "transaction_type": "S",
      "shares_after_transaction": "30373"
    },
    {
      "id": 27645,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-14",
      "transaction_shares": "439",
      "transaction_price": "937.94",
      "transaction_type": "S",
      "shares_after_transaction": "30373"
    },
    {
      "id": 44617,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-14",
      "transaction_shares": "439",
      "transaction_price": "937.94",
      "transaction_type": "S",
      "shares_after_transaction": "30373"
    },
    {
      "id": 64331,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-14",
      "transaction_shares": "439",
      "transaction_price": "937.94",
      "transaction_type": "S",
      "shares_after_transaction": "30373"
    },
    {
      "id": 86288,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-14",
      "transaction_shares": "439",
      "transaction_price": "937.94",
      "transaction_type": "S",
      "shares_after_transaction": "30373"
    },
    {
      "id": 110516,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-14",
      "transaction_shares": "439",
      "transaction_price": "937.94",
      "transaction_type": "S",
      "shares_after_transaction": "30373"
    },
    {
      "id": 136668,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-14",
      "transaction_shares": "439",
      "transaction_price": "937.94",
      "transaction_type": "S",
      "shares_after_transaction": "30373"
    },
    {
      "id": 164812,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-14",
      "transaction_shares": "439",
      "transaction_price": "937.94",
      "transaction_type": "S",
      "shares_after_transaction": "30373"
    },
    {
      "id": 195416,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-14",
      "transaction_shares": "439",
      "transaction_price": "937.94",
      "transaction_type": "S",
      "shares_after_transaction": "30373"
    },
    {
      "id": 228304,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-14",
      "transaction_shares": "439",
      "transaction_price": "937.94",
      "transaction_type": "S",
      "shares_after_transaction": "30373"
    },
    {
      "id": 263918,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-14",
      "transaction_shares": "439",
      "transaction_price": "937.94",
      "transaction_type": "S",
      "shares_after_transaction": "30373"
    },
    {
      "id": 305186,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-14",
      "transaction_shares": "439",
      "transaction_price": "937.94",
      "transaction_type": "S",
      "shares_after_transaction": "30373"
    },
    {
      "id": 4671,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-09",
      "transaction_shares": "12250",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "32628"
    },
    {
      "id": 4675,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "344",
      "transaction_price": "950.49",
      "transaction_type": "S",
      "shares_after_transaction": "18947"
    },
    {
      "id": 14696,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-09",
      "transaction_shares": "12250",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "32628"
    },
    {
      "id": 14701,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "344",
      "transaction_price": "950.49",
      "transaction_type": "S",
      "shares_after_transaction": "18947"
    },
    {
      "id": 27652,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-09",
      "transaction_shares": "12250",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "32628"
    },
    {
      "id": 27657,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "344",
      "transaction_price": "950.49",
      "transaction_type": "S",
      "shares_after_transaction": "18947"
    },
    {
      "id": 44624,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-09",
      "transaction_shares": "12250",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "32628"
    },
    {
      "id": 44633,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "344",
      "transaction_price": "950.49",
      "transaction_type": "S",
      "shares_after_transaction": "18947"
    },
    {
      "id": 64340,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-09",
      "transaction_shares": "12250",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "32628"
    },
    {
      "id": 64352,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "344",
      "transaction_price": "950.49",
      "transaction_type": "S",
      "shares_after_transaction": "18947"
    },
    {
      "id": 86297,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-09",
      "transaction_shares": "12250",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "32628"
    },
    {
      "id": 86311,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "344",
      "transaction_price": "950.49",
      "transaction_type": "S",
      "shares_after_transaction": "18947"
    },
    {
      "id": 110525,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-09",
      "transaction_shares": "12250",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "32628"
    },
    {
      "id": 110544,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "344",
      "transaction_price": "950.49",
      "transaction_type": "S",
      "shares_after_transaction": "18947"
    },
    {
      "id": 136679,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-09",
      "transaction_shares": "12250",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "32628"
    },
    {
      "id": 136698,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "344",
      "transaction_price": "950.49",
      "transaction_type": "S",
      "shares_after_transaction": "18947"
    },
    {
      "id": 164823,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-09",
      "transaction_shares": "12250",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "32628"
    },
    {
      "id": 164842,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "344",
      "transaction_price": "950.49",
      "transaction_type": "S",
      "shares_after_transaction": "18947"
    },
    {
      "id": 195427,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-09",
      "transaction_shares": "12250",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "32628"
    },
    {
      "id": 195446,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "344",
      "transaction_price": "950.49",
      "transaction_type": "S",
      "shares_after_transaction": "18947"
    },
    {
      "id": 228318,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-09",
      "transaction_shares": "12250",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "32628"
    },
    {
      "id": 228339,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "344",
      "transaction_price": "950.49",
      "transaction_type": "S",
      "shares_after_transaction": "18947"
    },
    {
      "id": 263934,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-09",
      "transaction_shares": "12250",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "32628"
    },
    {
      "id": 263958,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "344",
      "transaction_price": "950.49",
      "transaction_type": "S",
      "shares_after_transaction": "18947"
    },
    {
      "id": 305202,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-09",
      "transaction_shares": "12250",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "32628"
    },
    {
      "id": 305226,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "344",
      "transaction_price": "950.49",
      "transaction_type": "S",
      "shares_after_transaction": "18947"
    },
    {
      "id": 4676,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 14703,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 27660,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 44638,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 64358,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 86317,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 110550,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 136704,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 164848,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 195452,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 228345,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 263965,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 305233,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 4670,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-07",
      "transaction_shares": "1000",
      "transaction_price": "950.0",
      "transaction_type": "S",
      "shares_after_transaction": "38543"
    },
    {
      "id": 4677,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-07",
      "transaction_shares": "100",
      "transaction_price": "947.34",
      "transaction_type": "S",
      "shares_after_transaction": "59956"
    },
    {
      "id": 14695,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-07",
      "transaction_shares": "1000",
      "transaction_price": "950.0",
      "transaction_type": "S",
      "shares_after_transaction": "38543"
    },
    {
      "id": 14704,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-07",
      "transaction_shares": "100",
      "transaction_price": "947.34",
      "transaction_type": "S",
      "shares_after_transaction": "59956"
    },
    {
      "id": 27651,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-07",
      "transaction_shares": "1000",
      "transaction_price": "950.0",
      "transaction_type": "S",
      "shares_after_transaction": "38543"
    },
    {
      "id": 27661,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-07",
      "transaction_shares": "100",
      "transaction_price": "947.34",
      "transaction_type": "S",
      "shares_after_transaction": "59956"
    },
    {
      "id": 44623,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-07",
      "transaction_shares": "1000",
      "transaction_price": "950.0",
      "transaction_type": "S",
      "shares_after_transaction": "38543"
    },
    {
      "id": 44639,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-07",
      "transaction_shares": "100",
      "transaction_price": "947.34",
      "transaction_type": "S",
      "shares_after_transaction": "59956"
    },
    {
      "id": 64339,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-07",
      "transaction_shares": "1000",
      "transaction_price": "950.0",
      "transaction_type": "S",
      "shares_after_transaction": "38543"
    },
    {
      "id": 64360,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-07",
      "transaction_shares": "100",
      "transaction_price": "947.34",
      "transaction_type": "S",
      "shares_after_transaction": "59956"
    },
    {
      "id": 86296,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-07",
      "transaction_shares": "1000",
      "transaction_price": "950.0",
      "transaction_type": "S",
      "shares_after_transaction": "38543"
    },
    {
      "id": 86319,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-07",
      "transaction_shares": "100",
      "transaction_price": "947.34",
      "transaction_type": "S",
      "shares_after_transaction": "59956"
    },
    {
      "id": 110524,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-07",
      "transaction_shares": "1000",
      "transaction_price": "950.0",
      "transaction_type": "S",
      "shares_after_transaction": "38543"
    },
    {
      "id": 110553,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-07",
      "transaction_shares": "100",
      "transaction_price": "947.34",
      "transaction_type": "S",
      "shares_after_transaction": "59956"
    },
    {
      "id": 136678,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-07",
      "transaction_shares": "1000",
      "transaction_price": "950.0",
      "transaction_type": "S",
      "shares_after_transaction": "38543"
    },
    {
      "id": 136707,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-07",
      "transaction_shares": "100",
      "transaction_price": "947.34",
      "transaction_type": "S",
      "shares_after_transaction": "59956"
    },
    {
      "id": 164822,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-07",
      "transaction_shares": "1000",
      "transaction_price": "950.0",
      "transaction_type": "S",
      "shares_after_transaction": "38543"
    },
    {
      "id": 164851,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-07",
      "transaction_shares": "100",
      "transaction_price": "947.34",
      "transaction_type": "S",
      "shares_after_transaction": "59956"
    },
    {
      "id": 195426,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-07",
      "transaction_shares": "1000",
      "transaction_price": "950.0",
      "transaction_type": "S",
      "shares_after_transaction": "38543"
    },
    {
      "id": 195456,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-07",
      "transaction_shares": "100",
      "transaction_price": "947.34",
      "transaction_type": "S",
      "shares_after_transaction": "59956"
    },
    {
      "id": 228317,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-07",
      "transaction_shares": "1000",
      "transaction_price": "950.0",
      "transaction_type": "S",
      "shares_after_transaction": "38543"
    },
    {
      "id": 228350,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-07",
      "transaction_shares": "100",
      "transaction_price": "947.34",
      "transaction_type": "S",
      "shares_after_transaction": "59956"
    },
    {
      "id": 263933,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-07",
      "transaction_shares": "1000",
      "transaction_price": "950.0",
      "transaction_type": "S",
      "shares_after_transaction": "38543"
    },
    {
      "id": 263972,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-07",
      "transaction_shares": "100",
      "transaction_price": "947.34",
      "transaction_type": "S",
      "shares_after_transaction": "59956"
    },
    {
      "id": 305201,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-07",
      "transaction_shares": "1000",
      "transaction_price": "950.0",
      "transaction_type": "S",
      "shares_after_transaction": "38543"
    },
    {
      "id": 305240,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-07",
      "transaction_shares": "100",
      "transaction_price": "947.34",
      "transaction_type": "S",
      "shares_after_transaction": "59956"
    },
    {
      "id": 4662,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-05",
      "transaction_shares": "1000",
      "transaction_price": "934.71",
      "transaction_type": "S",
      "shares_after_transaction": "13789"
    },
    {
      "id": 14680,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-05",
      "transaction_shares": "1000",
      "transaction_price": "934.71",
      "transaction_type": "S",
      "shares_after_transaction": "13789"
    },
    {
      "id": 27635,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-05",
      "transaction_shares": "1000",
      "transaction_price": "934.71",
      "transaction_type": "S",
      "shares_after_transaction": "13789"
    },
    {
      "id": 44603,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-05",
      "transaction_shares": "1000",
      "transaction_price": "934.71",
      "transaction_type": "S",
      "shares_after_transaction": "13789"
    },
    {
      "id": 64313,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-05",
      "transaction_shares": "1000",
      "transaction_price": "934.71",
      "transaction_type": "S",
      "shares_after_transaction": "13789"
    },
    {
      "id": 86269,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-05",
      "transaction_shares": "1000",
      "transaction_price": "934.71",
      "transaction_type": "S",
      "shares_after_transaction": "13789"
    },
    {
      "id": 110492,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-05",
      "transaction_shares": "1000",
      "transaction_price": "934.71",
      "transaction_type": "S",
      "shares_after_transaction": "13789"
    },
    {
      "id": 136642,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-05",
      "transaction_shares": "1000",
      "transaction_price": "934.71",
      "transaction_type": "S",
      "shares_after_transaction": "13789"
    },
    {
      "id": 164784,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-05",
      "transaction_shares": "1000",
      "transaction_price": "934.71",
      "transaction_type": "S",
      "shares_after_transaction": "13789"
    },
    {
      "id": 195387,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-05",
      "transaction_shares": "1000",
      "transaction_price": "934.71",
      "transaction_type": "S",
      "shares_after_transaction": "13789"
    },
    {
      "id": 228268,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-05",
      "transaction_shares": "1000",
      "transaction_price": "934.71",
      "transaction_type": "S",
      "shares_after_transaction": "13789"
    },
    {
      "id": 263879,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-05",
      "transaction_shares": "1000",
      "transaction_price": "934.71",
      "transaction_type": "S",
      "shares_after_transaction": "13789"
    },
    {
      "id": 305147,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-05",
      "transaction_shares": "1000",
      "transaction_price": "934.71",
      "transaction_type": "S",
      "shares_after_transaction": "13789"
    },
    {
      "id": 4664,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-02",
      "transaction_shares": "30750",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "82769"
    },
    {
      "id": 4669,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23974"
    },
    {
      "id": 14685,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-02",
      "transaction_shares": "30750",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "82769"
    },
    {
      "id": 14694,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23974"
    },
    {
      "id": 27640,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-02",
      "transaction_shares": "30750",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "82769"
    },
    {
      "id": 27650,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23974"
    },
    {
      "id": 44608,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-02",
      "transaction_shares": "30750",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "82769"
    },
    {
      "id": 44622,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23974"
    },
    {
      "id": 64319,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-02",
      "transaction_shares": "30750",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "82769"
    },
    {
      "id": 64337,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23974"
    },
    {
      "id": 86275,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-02",
      "transaction_shares": "30750",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "82769"
    },
    {
      "id": 86294,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23974"
    },
    {
      "id": 110499,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-02",
      "transaction_shares": "30750",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "82769"
    },
    {
      "id": 110522,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23974"
    },
    {
      "id": 136649,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-02",
      "transaction_shares": "30750",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "82769"
    },
    {
      "id": 136675,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23974"
    },
    {
      "id": 164792,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-02",
      "transaction_shares": "30750",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "82769"
    },
    {
      "id": 164819,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23974"
    },
    {
      "id": 195395,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-02",
      "transaction_shares": "30750",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "82769"
    },
    {
      "id": 195423,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23974"
    },
    {
      "id": 228278,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-02",
      "transaction_shares": "30750",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "82769"
    },
    {
      "id": 228313,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23974"
    },
    {
      "id": 263891,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-02",
      "transaction_shares": "30750",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "82769"
    },
    {
      "id": 263928,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23974"
    },
    {
      "id": 305159,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-02",
      "transaction_shares": "30750",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "82769"
    },
    {
      "id": 305196,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23974"
    },
    {
      "id": 4661,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "1",
      "transaction_price": "939.53",
      "transaction_type": "S",
      "shares_after_transaction": "18481"
    },
    {
      "id": 4663,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-01",
      "transaction_shares": "273",
      "transaction_price": "945.61",
      "transaction_type": "S",
      "shares_after_transaction": "14789"
    },
    {
      "id": 14679,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "1",
      "transaction_price": "939.53",
      "transaction_type": "S",
      "shares_after_transaction": "18481"
    },
    {
      "id": 14684,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-01",
      "transaction_shares": "273",
      "transaction_price": "945.61",
      "transaction_type": "S",
      "shares_after_transaction": "14789"
    },
    {
      "id": 27634,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "1",
      "transaction_price": "939.53",
      "transaction_type": "S",
      "shares_after_transaction": "18481"
    },
    {
      "id": 27639,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-01",
      "transaction_shares": "273",
      "transaction_price": "945.61",
      "transaction_type": "S",
      "shares_after_transaction": "14789"
    },
    {
      "id": 44602,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "1",
      "transaction_price": "939.53",
      "transaction_type": "S",
      "shares_after_transaction": "18481"
    },
    {
      "id": 44607,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-01",
      "transaction_shares": "273",
      "transaction_price": "945.61",
      "transaction_type": "S",
      "shares_after_transaction": "14789"
    },
    {
      "id": 64312,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "1",
      "transaction_price": "939.53",
      "transaction_type": "S",
      "shares_after_transaction": "18481"
    },
    {
      "id": 64317,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-01",
      "transaction_shares": "273",
      "transaction_price": "945.61",
      "transaction_type": "S",
      "shares_after_transaction": "14789"
    },
    {
      "id": 86268,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "1",
      "transaction_price": "939.53",
      "transaction_type": "S",
      "shares_after_transaction": "18481"
    },
    {
      "id": 86273,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-01",
      "transaction_shares": "273",
      "transaction_price": "945.61",
      "transaction_type": "S",
      "shares_after_transaction": "14789"
    },
    {
      "id": 110491,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "1",
      "transaction_price": "939.53",
      "transaction_type": "S",
      "shares_after_transaction": "18481"
    },
    {
      "id": 110497,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-01",
      "transaction_shares": "273",
      "transaction_price": "945.61",
      "transaction_type": "S",
      "shares_after_transaction": "14789"
    },
    {
      "id": 136641,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "1",
      "transaction_price": "939.53",
      "transaction_type": "S",
      "shares_after_transaction": "18481"
    },
    {
      "id": 136647,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-01",
      "transaction_shares": "273",
      "transaction_price": "945.61",
      "transaction_type": "S",
      "shares_after_transaction": "14789"
    },
    {
      "id": 164783,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "1",
      "transaction_price": "939.53",
      "transaction_type": "S",
      "shares_after_transaction": "18481"
    },
    {
      "id": 164789,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-01",
      "transaction_shares": "273",
      "transaction_price": "945.61",
      "transaction_type": "S",
      "shares_after_transaction": "14789"
    },
    {
      "id": 195386,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "1",
      "transaction_price": "939.53",
      "transaction_type": "S",
      "shares_after_transaction": "18481"
    },
    {
      "id": 195392,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-01",
      "transaction_shares": "273",
      "transaction_price": "945.61",
      "transaction_type": "S",
      "shares_after_transaction": "14789"
    },
    {
      "id": 228267,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "1",
      "transaction_price": "939.53",
      "transaction_type": "S",
      "shares_after_transaction": "18481"
    },
    {
      "id": 228275,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-01",
      "transaction_shares": "273",
      "transaction_price": "945.61",
      "transaction_type": "S",
      "shares_after_transaction": "14789"
    },
    {
      "id": 263878,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "1",
      "transaction_price": "939.53",
      "transaction_type": "S",
      "shares_after_transaction": "18481"
    },
    {
      "id": 263888,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-01",
      "transaction_shares": "273",
      "transaction_price": "945.61",
      "transaction_type": "S",
      "shares_after_transaction": "14789"
    },
    {
      "id": 305146,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "1",
      "transaction_price": "939.53",
      "transaction_type": "S",
      "shares_after_transaction": "18481"
    },
    {
      "id": 305156,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-01",
      "transaction_shares": "273",
      "transaction_price": "945.61",
      "transaction_type": "S",
      "shares_after_transaction": "14789"
    },
    {
      "id": 4674,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23856"
    },
    {
      "id": 14700,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23856"
    },
    {
      "id": 27656,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23856"
    },
    {
      "id": 44630,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23856"
    },
    {
      "id": 64347,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23856"
    },
    {
      "id": 86305,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23856"
    },
    {
      "id": 110537,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23856"
    },
    {
      "id": 136691,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23856"
    },
    {
      "id": 164835,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23856"
    },
    {
      "id": 195439,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23856"
    },
    {
      "id": 228332,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23856"
    },
    {
      "id": 263951,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23856"
    },
    {
      "id": 305219,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23856"
    },
    {
      "id": 4667,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-30",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 14692,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-30",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 27648,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-30",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 44620,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-30",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 64335,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-30",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 86292,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-30",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 110520,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-30",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 136673,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-30",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 164817,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-30",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 195421,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-30",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 228310,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-30",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 263925,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-30",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 305193,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-30",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 4665,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "GOLDSTEIN JOSEPH L",
      "reporting_owner_cik": "0001225474",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-23",
      "transaction_shares": "2707",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "9089"
    },
    {
      "id": 4672,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2024-01-23",
      "transaction_shares": "5000",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "21860"
    },
    {
      "id": 4673,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-23",
      "transaction_shares": "1100",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "24084"
    },
    {
      "id": 14687,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "GOLDSTEIN JOSEPH L",
      "reporting_owner_cik": "0001225474",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-23",
      "transaction_shares": "2707",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "9089"
    },
    {
      "id": 14697,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2024-01-23",
      "transaction_shares": "5000",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "21860"
    },
    {
      "id": 14699,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-23",
      "transaction_shares": "1100",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "24084"
    },
    {
      "id": 27643,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "GOLDSTEIN JOSEPH L",
      "reporting_owner_cik": "0001225474",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-23",
      "transaction_shares": "2707",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "9089"
    },
    {
      "id": 27653,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2024-01-23",
      "transaction_shares": "5000",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "21860"
    },
    {
      "id": 27655,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-23",
      "transaction_shares": "1100",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "24084"
    },
    {
      "id": 44614,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "GOLDSTEIN JOSEPH L",
      "reporting_owner_cik": "0001225474",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-23",
      "transaction_shares": "2707",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "9089"
    },
    {
      "id": 44625,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2024-01-23",
      "transaction_shares": "5000",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "21860"
    },
    {
      "id": 44629,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-23",
      "transaction_shares": "1100",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "24084"
    },
    {
      "id": 64327,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "GOLDSTEIN JOSEPH L",
      "reporting_owner_cik": "0001225474",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-23",
      "transaction_shares": "2707",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "9089"
    },
    {
      "id": 64341,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2024-01-23",
      "transaction_shares": "5000",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "21860"
    },
    {
      "id": 64346,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-23",
      "transaction_shares": "1100",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "24084"
    },
    {
      "id": 86284,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "GOLDSTEIN JOSEPH L",
      "reporting_owner_cik": "0001225474",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-23",
      "transaction_shares": "2707",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "9089"
    },
    {
      "id": 86298,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2024-01-23",
      "transaction_shares": "5000",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "21860"
    },
    {
      "id": 86303,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-23",
      "transaction_shares": "1100",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "24084"
    },
    {
      "id": 110512,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "GOLDSTEIN JOSEPH L",
      "reporting_owner_cik": "0001225474",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-23",
      "transaction_shares": "2707",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "9089"
    },
    {
      "id": 110527,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2024-01-23",
      "transaction_shares": "5000",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "21860"
    },
    {
      "id": 110535,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-23",
      "transaction_shares": "1100",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "24084"
    },
    {
      "id": 136662,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "GOLDSTEIN JOSEPH L",
      "reporting_owner_cik": "0001225474",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-23",
      "transaction_shares": "2707",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "9089"
    },
    {
      "id": 136681,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2024-01-23",
      "transaction_shares": "5000",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "21860"
    },
    {
      "id": 136689,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-23",
      "transaction_shares": "1100",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "24084"
    },
    {
      "id": 164806,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "GOLDSTEIN JOSEPH L",
      "reporting_owner_cik": "0001225474",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-23",
      "transaction_shares": "2707",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "9089"
    },
    {
      "id": 164825,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2024-01-23",
      "transaction_shares": "5000",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "21860"
    },
    {
      "id": 164833,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-23",
      "transaction_shares": "1100",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "24084"
    },
    {
      "id": 195410,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "GOLDSTEIN JOSEPH L",
      "reporting_owner_cik": "0001225474",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-23",
      "transaction_shares": "2707",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "9089"
    },
    {
      "id": 195429,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2024-01-23",
      "transaction_shares": "5000",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "21860"
    },
    {
      "id": 195437,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-23",
      "transaction_shares": "1100",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "24084"
    },
    {
      "id": 228298,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "GOLDSTEIN JOSEPH L",
      "reporting_owner_cik": "0001225474",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-23",
      "transaction_shares": "2707",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "9089"
    },
    {
      "id": 228321,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2024-01-23",
      "transaction_shares": "5000",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "21860"
    },
    {
      "id": 228330,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-23",
      "transaction_shares": "1100",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "24084"
    },
    {
      "id": 263912,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "GOLDSTEIN JOSEPH L",
      "reporting_owner_cik": "0001225474",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-23",
      "transaction_shares": "2707",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "9089"
    },
    {
      "id": 263937,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2024-01-23",
      "transaction_shares": "5000",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "21860"
    },
    {
      "id": 263949,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-23",
      "transaction_shares": "1100",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "24084"
    },
    {
      "id": 305180,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "GOLDSTEIN JOSEPH L",
      "reporting_owner_cik": "0001225474",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-23",
      "transaction_shares": "2707",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "9089"
    },
    {
      "id": 305205,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2024-01-23",
      "transaction_shares": "5000",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "21860"
    },
    {
      "id": 305217,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-23",
      "transaction_shares": "1100",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "24084"
    },
    {
      "id": 44610,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-01-02",
      "transaction_shares": "16848",
      "transaction_price": "900.0",
      "transaction_type": "S",
      "shares_after_transaction": "180000"
    },
    {
      "id": 64323,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-01-02",
      "transaction_shares": "16848",
      "transaction_price": "900.0",
      "transaction_type": "S",
      "shares_after_transaction": "180000"
    },
    {
      "id": 86279,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-01-02",
      "transaction_shares": "16848",
      "transaction_price": "900.0",
      "transaction_type": "S",
      "shares_after_transaction": "180000"
    },
    {
      "id": 110504,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-01-02",
      "transaction_shares": "16848",
      "transaction_price": "900.0",
      "transaction_type": "S",
      "shares_after_transaction": "180000"
    },
    {
      "id": 136654,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-01-02",
      "transaction_shares": "16848",
      "transaction_price": "900.0",
      "transaction_type": "S",
      "shares_after_transaction": "180000"
    },
    {
      "id": 164798,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-01-02",
      "transaction_shares": "16848",
      "transaction_price": "900.0",
      "transaction_type": "S",
      "shares_after_transaction": "180000"
    },
    {
      "id": 195401,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-01-02",
      "transaction_shares": "16848",
      "transaction_price": "900.0",
      "transaction_type": "S",
      "shares_after_transaction": "180000"
    },
    {
      "id": 228288,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-01-02",
      "transaction_shares": "16848",
      "transaction_price": "900.0",
      "transaction_type": "S",
      "shares_after_transaction": "180000"
    },
    {
      "id": 263901,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-01-02",
      "transaction_shares": "16848",
      "transaction_price": "900.0",
      "transaction_type": "S",
      "shares_after_transaction": "180000"
    },
    {
      "id": 305169,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-01-02",
      "transaction_shares": "16848",
      "transaction_price": "900.0",
      "transaction_type": "S",
      "shares_after_transaction": "180000"
    }
  ]
}